SI-BONE, Inc. Chief Executive Officer Laura Francis filed a Form 4 on November 18, 2026, disclosing the sale of 16,854 shares of common stock across six transactions on November 16 and 17, 2026, primarily to cover tax withholding obligations arising from the vesting of restricted stock units.

Key Highlights

  • Reporting person: Laura Francis, Director and Chief Executive Officer of SI-BONE, Inc. (NASDAQ:SIBN)
  • Five sell-to-cover transactions on November 16, 2026: 3,892 shares at a weighted average of $23.3331, 2,235 shares at $23.3256, 3,203 shares at $23.3229, 3,651 shares at $23.3321, and 1,972 shares at $23.3191, all to satisfy RSU tax withholding obligations
  • One 10b5-1 plan sale on November 17, 2026: 1,901 shares at a weighted average of $23.1763, executed pursuant to a trading plan dated June 13, 2025
  • Direct beneficial ownership following transactions: 351,275 shares directly held, including 326,327 shares issuable upon settlement of restricted stock units
  • Indirect beneficial ownership: 304,256 shares held by The David & Laura Joint Rev Tr
  • All sell-to-cover transactions: described in the filing as not representing discretionary trades by the reporting person

Francis RSU Tax-Withholding Sales and 10b5-1 Transaction Details

According to the filing, five of the six reported sales on November 16, 2026, were required to be made by Laura Francis to cover tax withholding obligations connected to the vesting of restricted stock units. The filing states that these sales "satisf[y] the tax withholding obligations to be funded by a 'sell to cover' transaction and do not represent a discretionary trade by the Reporting Person." Each of these five transactions was executed in multiple trades, with the prices reported reflecting weighted average sale prices across ranges between approximately $23.25 and $23.44 per share.

The sixth transaction, covering 1,901 shares sold on November 17, 2026, at a weighted average price of $23.1763, was effected pursuant to a 10b5-1 trading plan dated June 13, 2025. The filing notes this transaction also involved multiple trades at prices ranging from $23.03 to $23.43. The form was signed by Michael A. Pisetsky as Attorney-in-Fact for Laura A. Francis on November 18, 2026.

Following all reported transactions, Francis directly held 351,275 shares, a figure the filing notes includes 326,327 shares issuable upon settlement of restricted stock units, with each unit representing a contingent right to receive one share of SI-BONE common stock. An additional 304,256 shares are held indirectly through The David & Laura Joint Rev Tr, as disclosed in Table I of the filing.

What Was Disclosed

SI-BONE CEO Laura Francis reported the disposal of 16,854 shares of common stock between November 16 and 17, 2026, through five RSU tax-withholding sell-to-cover transactions and one 10b5-1 plan sale, leaving her with 351,275 directly held shares and 304,256 shares held indirectly by trust.